Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Anna A. Agan, MPH
Senior Research Analyst
Department of Population Medicine, Harvard Pilgrim Health Care Institute
Poster(s):
(332) Background Rates of Neuroinflammatory Disorders and Atrial Fibrillation – Conditions of Interest for Vaccine Safety Studies
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
(347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
